This website sets cookies which are used to offer a personalized experience on our website, generate statistics, and realize advertising or social network tracking. Find out more about our Privacy & Cookie policy and how to manage them on your browser. You can change your cookie settings at any time.

Innovate NanoMedicine 2019
(inmc 2019)

Hilton Americas – Houston | February 7-9, 2019



  • Piotr_Grodzinski_NANO.png

    Dr. Piotr Grodzinski

    National Cancer Institute
    Chief of Nanodelivery Systems, NCI/DCTD/CIP
  • Dr_Mauro_Ferrari_Nano_128px.png

    Dr. Mauro Ferrari

    KEYNOTE: Houston Methodist Research Institute
    President & CEO
  • Dr_Alimorad_Farshchian_INMC.png

    Dr. Alimorad Farshchian

    The Center for Regenerative Medicine
  • Ilise_Feitshans_Nano_128px.png

    Dr. Ilise Feitshans

    European Scientific Institute
    Fellow in International law of Nanotechnology
  • Alissa_Gentile_NANO.png

    Alissa Gentile

    The Leukemia & Lymphoma Society
    Director Clinical Trial Support Center
  • Dr_Emily_Bolch_INMC.png

    Dr. Emily Bolch

    Duke Cancer Institute - Oncology CRU
    Research & Program Leader, GI & Phase I Oncology Clinical Trials
  • Dr_Tarek_Fadel_INMC.png

    Dr. Tarek R. Fadel

    The Koch Institute for Integrative Cancer Research, MIT
    Assistant Director, The Marble Center for Cancer Nanomedicine
  • Hossein_Ghanbari_NANO.png

    Dr. Hossein A. Ghanbari

    Sensei Biotherapeutics
    Chairman & CSO
  • Dr_Shawn_Chen_NANO.png

    Dr. Shawn Chen

    National Institute of Biomedical Imaging and Bioengineering
    Senior Investigator Laboratory of Molecular Imaging and Nanomedicine (LOMIN)
  • Alice_Fan_INMC_128px.png

    Dr. Alice C. Fan

    Stanford University School of Medicine
    Assistant Professor in Oncology
  • Takashi_Kishimoto_INMC_128px.png

    Dr. Takashi Kei Kishimoto

    Selecta Biosciences
    Chief Science Officer
  • Dr_Alessandro_Grattoni_Nano_128px.png

    Dr. Alessandro Grattoni

    Chairman & Professor, Department of Nanomedicine
    Houston Methodist Research Institute
  • Christine_Hendren_NANO.png

    Dr. Christine Hendren

    Executive Director
  • Dr_Ying_Liu_NANO.png

    Dr. Ying Liu

    University of Illinois at Chicago, Department of Chemical Engineering
    Associate Professor
  • Bree_Martin_INMC_128px.png

    Bree Martin

    Audentes Therapeutics Inc.
    Vice President Development Operations
  • Amrinder_Nain_NANO.png

    Dr. Amrinder Nain

    College of Mechanical Engineering, Virginia Tech
    Associate Professor
  • Dr_Len_Pagliaro_Nano_128px.png

    Dr. Len Pagliaro

    Siva Therapeutics
    Chief Executive Officer
  • Dr_Anastasios_Papadiamantis_INMC.png

    Dr. Anastasios Papadiamantis

    School of Geography, Earth and Environmental Sciences of the University of Birmingham
    Research Fellow NanoCommons
  • Dr_Haifa_Shen_Nano_128px.png

    Dr. Haifa Shen

    Houston Methodist Research Institute
    Professor, Department of Nanomedicine
  • Dr_Mervi_Heiskanen_NANO.png

    Dr. Mervi Heiskanen

    National Cancer Institute
    Center for Biomedical Informatics & Information Technology
  • Ivandick_Cruzelles_Rodrigues_Nano_128px.png

    Ivandick Cruzelles Rodrigues

    Universidade Presbiteriana Mackezie
    Faculdade de Direito
  • Thomas_Webster_NANO.png

    Dr. Thomas Webster

    Northeastern University College of Engineering
    Professor and Department Chair, Chemical Engineering
  • Dr_Jim_Willson_INMC.png

    Dr. Jim Willson

    Cancer Prevention and Research Institute of Texas
    Chief Scientific Officer

Welcome to Innovate NanoMedicine!

On behalf of the Committee, it is an honor to welcome you to the annual Innovate NanoMedicine 2019 Forum. INMC 2019 will be held from 7th to 9th February 2019 in beautiful Houston, Texas under a modern conference perspective environment. The objectives of this forum are to focus on the benefits of human health through nanomedicines and regenerative medicines in clinical trials and commercialization.

INMC 2019 will foster interdisciplinary collaborations among industry representatives, clinicians, scientists, government, funding agencies, graduates and professors to strengthen the understanding that science must work alongside industry and market leaders such that we ensure emerging medicines enhance the quality of patient’s life. We are committed to an exchange of ideas and cultivating collaborations and cross-promotions of organizations and industries. INMC 2019 is committed to delivering an outstanding conference to our delegates with renowned speakers, academic institutions, pharmaceutical and biotechnology companies creating unique learning experiences within the nanomedicine clinical pipeline.

Look forward to seeing you in Houston!

Warm regards,
Dr. Javed Khan
Conference Chair